“Response to Ustekinumab in a Patient with Severe Psoriasis when Adalimumab Dose Escalation Fails ”, J. Pharm. Nutr. Sci., vol. 4, no. 2, pp. 131–134, May 2014, doi: 10.6000/1927-5951.2014.04.02.9.